A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation
{{output}}
Introduction: Targeted α-particle therapy agents have shown promising responses in patients who have developed resistance to β--particle emitting radionuclides, albeit off-target toxicity remains a concern. Astatine-211 emits o... ...
